Deucravacitinib-d3

SL-9386

Deucravacitinib-d₃, >98%

Related CAS No. : [1609392-27-9] of the parent compound

IUPAC Name : 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-(methyl-d₃)-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d₃)pyridazine-3-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Deucravacitinib, which is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases.

References : Wrobleski S. T. et al.: J. Med. Chem. 60(20), 8973-8995, 2019; Catlett I. et al.: Annals of the Rheumatic Diseases 76, 859, 2017.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.